[HTML][HTML] Ectopic and visceral fat deposition in aging, obesity, and idiopathic pulmonary fibrosis: an interconnected role
X Cheng, S Jiang, B Pan, W Xie, J Meng - Lipids in Health and Disease, 2023 - Springer
Idiopathic pulmonary fibrosis (IPF) is considered an age-related disease. Age-related
changes, along with other factors such as obesity, hormonal imbalances, and various …
changes, along with other factors such as obesity, hormonal imbalances, and various …
The impact of nintedanib and pirfenidone on lung function and survival in patients with idiopathic pulmonary fibrosis in real-life setting
G Santos, A Fabiano, PC Mota, I Rodrigues… - Pulmonary …, 2023 - Elsevier
Background Idiopathic pulmonary fibrosis (IPF) is a chronic, fibrosing interstitial pneumonia
of unknown cause that is associated with radiological and/or histological features of usual …
of unknown cause that is associated with radiological and/or histological features of usual …
[HTML][HTML] Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study
B Ozaltin, R Chapman, MQU Arfeen, N Fitzpatick… - Respiratory …, 2024 - Springer
Background Our study examined whether prevalent and incident comorbidities are
increased in idiopathic pulmonary fibrosis (IPF) patients when compared to matched chronic …
increased in idiopathic pulmonary fibrosis (IPF) patients when compared to matched chronic …
[HTML][HTML] Effects of comorbid chronic kidney disease on mortality in idiopathic pulmonary fibrosis patients and influence of pirfenidone
YS Jo, KJ Kim, CK Rhee, YH Kim - Scientific Reports, 2023 - nature.com
Chronic kidney disease (CKD) is a comorbidity in idiopathic pulmonary fibrosis (IPF), and
managing IPF with CKD is challenging due to limited options for antifibrotic therapy. The aim …
managing IPF with CKD is challenging due to limited options for antifibrotic therapy. The aim …
[HTML][HTML] Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries–a real-world study from Finland
J Kaunisto, ER Salomaa, M Koivisto… - BMC Pulmonary …, 2023 - Springer
Background Currently, two disease-modifying antifibrotic drugs are indicated for the
treatment of idiopathic pulmonary fibrosis. The objective of this study was to analyse …
treatment of idiopathic pulmonary fibrosis. The objective of this study was to analyse …
Adherence to the ISHLT Protocol for the Referral of Patients with Idiopathic Pulmonary Fibrosis to the Transplantation Center among of Czech Centers for Interstitial …
M Sterclova, M Doubkova, L Sykorova… - Pulmonary …, 2024 - Wiley Online Library
There are limited data on referral rates and the number of patients with idiopathic pulmonary
fibrosis (IPF) who are eligible for lung transplantation. The aim of the present study was to …
fibrosis (IPF) who are eligible for lung transplantation. The aim of the present study was to …
[HTML][HTML] The Impact of Chronic Comorbidities on Outcomes in Acute Exacerbations of Idiopathic Pulmonary Fibrosis
SH Baig, EJ Yoo - Life, 2024 - mdpi.com
Introduction: Idiopathic pulmonary fibrosis is a chronic progressive lung disease of unknown
cause with a high associated mortality. We aimed to compare the impact of chronic medical …
cause with a high associated mortality. We aimed to compare the impact of chronic medical …
Assessment of prognosis in asbestosis
E Keskitalo - 2023 - oulurepo.oulu.fi
Original papers Original papers are not included in the electronic version of the dissertation.
Keskitalo, E., Varis, L., Bloigu, R., & Kaarteenaho, R.(2019). Bronchoalveolar cell differential …
Keskitalo, E., Varis, L., Bloigu, R., & Kaarteenaho, R.(2019). Bronchoalveolar cell differential …
[HTML][HTML] Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000–2016 cohort
The study aimed to investigate comorbidities, major adverse respiratory events, and
mortality in patients with idiopathic pulmonary fibrosis (IPF). We established an IPF cohort …
mortality in patients with idiopathic pulmonary fibrosis (IPF). We established an IPF cohort …
Risk of obstructive sleep apnea in idiopathic pulmonary fibrosis
Risk of obstructive sleep apnea in idiopathic pulmonary fibrosis Risk of obstructive sleep apnea
in idiopathic pulmonary fibrosis Eur J Intern Med. 2023 Apr:110:120-121. doi …
in idiopathic pulmonary fibrosis Eur J Intern Med. 2023 Apr:110:120-121. doi …